HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹-3.95 | ₹7.35 | ₹5.64 | ₹6.36 | ₹13.02 |
What is the latest Earnings Per Share (EPS) of HIKAL ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹-3.95 |
| Mar2025 | ₹7.35 |
| Mar2024 | ₹5.64 |
| Mar2023 | ₹6.36 |
| Mar2022 | ₹13.02 |
How is Earnings Per Share (EPS) of HIKAL Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹-3.95 | Negative | |
| Mar2025 | ₹7.35 | 30.32 | |
| Mar2024 | ₹5.64 | -11.32 | |
| Mar2023 | ₹6.36 | -51.15 | |
| Mar2022 | ₹13.02 | - | |
Compare Earnings Per Share (EPS) of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,694.7 Cr | 3.2% | -2.8% | -14.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,620.0 Cr | -0.2% | -5.1% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,714.0 Cr | -3.8% | -3.2% | 51.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,741.0 Cr | -1.7% | -7.7% | 29.9% | Stock Analytics | |
| CIPLA | ₹106,061.0 Cr | 0.6% | -3.8% | -11% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,339.0 Cr | 2.9% | 4.6% | 0.4% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 3.2% |
-2.8% |
-14.8% |
| SENSEX | 0.2% |
-2.8% |
-11.2% |
You may also like the below Video Courses